Idarucizumab Confirmed to Work as NOAC Reversal Agent (CME/CE)

(MedPage Today) -- Full cohort findings detail rapid effects independent of circulating dabigatran
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news